Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

How HIV became the virus we can treat

As the numbers of COVID-19 infections climb, it's easy to forget that there are still more than 1.2 million people in the U.S. living with another virus—human immunodeficiency virus, or HIV. When it first swept across the ...

HIV & AIDS

2010 to 2018 saw decrease in rate of death for people with HIV

(HealthDay)—From 2010 to 2018, there was a 36.6 percent decrease in the rate of death among persons with diagnosed HIV (PWDH), according to a Vital Signs report published in the Nov. 20 issue of the U.S. Centers for Disease ...

HIV & AIDS

Developing effective vaccines against SARS-CoV-2 and HIV

Researchers led by Raghavan Varadarajan, professor at the Molecular Biophysics Unit, Indian Institute of Science (IISc), are working toward developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.

HIV & AIDS

Canada should approve HIV self-testing

Canada should integrate self-testing for HIV into the health system to help reduce the burden of the disease, argues a commentary published in CMAJ (Canadian Medical Association Journal.

HIV & AIDS

New cause of inflammation in people with HIV identified

While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans—by up to five to 10 years—compared to ...

HIV & AIDS

Recommendations updated for HIV treatment, prevention

(HealthDay)—In a 2020 guideline from the International Antiviral Society-U.S., published online Oct. 14 in the Journal of the American Medical Association, updated recommendations are presented for the treatment and prevention ...

HIV & AIDS

Guidelines issued on managing infants exposed to HIV

(HealthDay)—In a clinical report from the American Academy of Pediatrics, published online Oct. 19 in Pediatrics, guidelines are presented for the evaluation and management of infants exposed to HIV.

HIV & AIDS

Unique program aims to educate Muslim teens on HIV prevention

Cultural taboos may leave Muslim American adolescents uninformed about romantic relationships and sex, placing them at risk of HIV and other sexually transmitted infections (STIs). A sex education program designed specifically ...

Medications

EU regulator greenlights first injectable HIV drug

The EU's medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people.

HIV & AIDS

Updated guidance for healthcare workers with HIV, hepatitis

In light of the low rate of transmission and advances in treatments for hepatitis B, hepatitis C, and HIV, the Society for Healthcare Epidemiology of America today released updated guidance for healthcare personnel living ...

HIV & AIDS

HIV epidemic: Successful use of self-tests in rural Africa

Despite significant progress in prevention and therapy, millions of people still get infected with HIV every year. The main burden of HIV/AIDS falls on Africa. To contain the epidemic, innovative methods are needed to enable ...